CD4<sup>+</sup> T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy

ABSTRACT Therapeutic strategies that provide effective and broad‐spectrum neutralization against HIV-1 infection are highly desirable. Here, we investigate the potential of nanoengineered CD4+ T cell membrane-coated nanoparticles (TNP) to neutralize a broad range of HIV-1 strains. TNP displayed outs...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gang Zhang, Grant R. Campbell, Qiangzhe Zhang, Erin Maule, Jonathan Hanna, Weiwei Gao, Liangfang Zhang, Stephen A. Spector
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
HIV
Acceso en línea:https://doaj.org/article/bcd1ffecf9ad42c095dd956fce43381e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bcd1ffecf9ad42c095dd956fce43381e
record_format dspace
spelling oai:doaj.org-article:bcd1ffecf9ad42c095dd956fce43381e2021-11-15T16:19:08ZCD4<sup>+</sup> T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy10.1128/mBio.00903-202150-7511https://doaj.org/article/bcd1ffecf9ad42c095dd956fce43381e2020-10-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00903-20https://doaj.org/toc/2150-7511ABSTRACT Therapeutic strategies that provide effective and broad‐spectrum neutralization against HIV-1 infection are highly desirable. Here, we investigate the potential of nanoengineered CD4+ T cell membrane-coated nanoparticles (TNP) to neutralize a broad range of HIV-1 strains. TNP displayed outstanding neutralizing breadth and potency; they neutralized all 125 HIV-1-pseudotyped viruses tested, including global subtypes/recombinant forms, and transmitted/founder viruses, with a geometric mean 80% inhibitory concentration (IC80) of 819 μg ml−1 (range, 72 to 8,570 μg ml−1). TNP also selectively bound to and induced autophagy in HIV-1-infected CD4+ T cells and macrophages, while having no effect on uninfected cells. This TNP-mediated autophagy inhibited viral release and reduced cell-associated HIV-1 in a dose- and phospholipase D1-dependent manner. Genetic or pharmacological inhibition of autophagy ablated this effect. Thus, we can use TNP as therapeutic agents to neutralize cell-free HIV-1 and to target HIV-1 gp120-expressing cells to decrease the HIV-1 reservoir. IMPORTANCE HIV-1 is a major global health challenge. The development of an effective vaccine and/or a therapeutic cure is a top priority. The creation of vaccines that focus an antibody response toward a particular epitope of a protein has shown promise, but the genetic diversity of HIV-1 hinders this progress. Here we developed an approach using nanoengineered CD4+ T cell membrane-coated nanoparticles (TNP). Not only do TNP effectively neutralize all strains of HIV-1, but they also selectively bind to infected cells and decrease the release of HIV-1 particles through an autophagy-dependent mechanism with no drug-induced off-target or cytotoxic effects on bystander cells.Gang ZhangGrant R. CampbellQiangzhe ZhangErin MauleJonathan HannaWeiwei GaoLiangfang ZhangStephen A. SpectorAmerican Society for MicrobiologyarticleHIVnanoparticleautophagyneutralizationCD4+ T cellmacrophageMicrobiologyQR1-502ENmBio, Vol 11, Iss 5 (2020)
institution DOAJ
collection DOAJ
language EN
topic HIV
nanoparticle
autophagy
neutralization
CD4+ T cell
macrophage
Microbiology
QR1-502
spellingShingle HIV
nanoparticle
autophagy
neutralization
CD4+ T cell
macrophage
Microbiology
QR1-502
Gang Zhang
Grant R. Campbell
Qiangzhe Zhang
Erin Maule
Jonathan Hanna
Weiwei Gao
Liangfang Zhang
Stephen A. Spector
CD4<sup>+</sup> T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy
description ABSTRACT Therapeutic strategies that provide effective and broad‐spectrum neutralization against HIV-1 infection are highly desirable. Here, we investigate the potential of nanoengineered CD4+ T cell membrane-coated nanoparticles (TNP) to neutralize a broad range of HIV-1 strains. TNP displayed outstanding neutralizing breadth and potency; they neutralized all 125 HIV-1-pseudotyped viruses tested, including global subtypes/recombinant forms, and transmitted/founder viruses, with a geometric mean 80% inhibitory concentration (IC80) of 819 μg ml−1 (range, 72 to 8,570 μg ml−1). TNP also selectively bound to and induced autophagy in HIV-1-infected CD4+ T cells and macrophages, while having no effect on uninfected cells. This TNP-mediated autophagy inhibited viral release and reduced cell-associated HIV-1 in a dose- and phospholipase D1-dependent manner. Genetic or pharmacological inhibition of autophagy ablated this effect. Thus, we can use TNP as therapeutic agents to neutralize cell-free HIV-1 and to target HIV-1 gp120-expressing cells to decrease the HIV-1 reservoir. IMPORTANCE HIV-1 is a major global health challenge. The development of an effective vaccine and/or a therapeutic cure is a top priority. The creation of vaccines that focus an antibody response toward a particular epitope of a protein has shown promise, but the genetic diversity of HIV-1 hinders this progress. Here we developed an approach using nanoengineered CD4+ T cell membrane-coated nanoparticles (TNP). Not only do TNP effectively neutralize all strains of HIV-1, but they also selectively bind to infected cells and decrease the release of HIV-1 particles through an autophagy-dependent mechanism with no drug-induced off-target or cytotoxic effects on bystander cells.
format article
author Gang Zhang
Grant R. Campbell
Qiangzhe Zhang
Erin Maule
Jonathan Hanna
Weiwei Gao
Liangfang Zhang
Stephen A. Spector
author_facet Gang Zhang
Grant R. Campbell
Qiangzhe Zhang
Erin Maule
Jonathan Hanna
Weiwei Gao
Liangfang Zhang
Stephen A. Spector
author_sort Gang Zhang
title CD4<sup>+</sup> T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy
title_short CD4<sup>+</sup> T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy
title_full CD4<sup>+</sup> T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy
title_fullStr CD4<sup>+</sup> T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy
title_full_unstemmed CD4<sup>+</sup> T Cell-Mimicking Nanoparticles Broadly Neutralize HIV-1 and Suppress Viral Replication through Autophagy
title_sort cd4<sup>+</sup> t cell-mimicking nanoparticles broadly neutralize hiv-1 and suppress viral replication through autophagy
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/bcd1ffecf9ad42c095dd956fce43381e
work_keys_str_mv AT gangzhang cd4supsuptcellmimickingnanoparticlesbroadlyneutralizehiv1andsuppressviralreplicationthroughautophagy
AT grantrcampbell cd4supsuptcellmimickingnanoparticlesbroadlyneutralizehiv1andsuppressviralreplicationthroughautophagy
AT qiangzhezhang cd4supsuptcellmimickingnanoparticlesbroadlyneutralizehiv1andsuppressviralreplicationthroughautophagy
AT erinmaule cd4supsuptcellmimickingnanoparticlesbroadlyneutralizehiv1andsuppressviralreplicationthroughautophagy
AT jonathanhanna cd4supsuptcellmimickingnanoparticlesbroadlyneutralizehiv1andsuppressviralreplicationthroughautophagy
AT weiweigao cd4supsuptcellmimickingnanoparticlesbroadlyneutralizehiv1andsuppressviralreplicationthroughautophagy
AT liangfangzhang cd4supsuptcellmimickingnanoparticlesbroadlyneutralizehiv1andsuppressviralreplicationthroughautophagy
AT stephenaspector cd4supsuptcellmimickingnanoparticlesbroadlyneutralizehiv1andsuppressviralreplicationthroughautophagy
_version_ 1718426928581443584